[Malignant peritoneal mesothelioma]

V Scripcariu1, Elena Dajbog, L Lefter

  • 1Clinica aIII-a Chirurgicală si Centrul de Cercetare in Chirurgia Oncologică si Training in Chirurgie Generală, Spitalul "Sf. Spiridon", U.M.E "Gr. T. Popa" Iasi. vscripcariu@gmail.com

Chirurgia (Bucharest, Romania : 1990)
|February 8, 2007
PubMed

Insights

This case report details a patient with malignant peritoneal mesothelioma, a rare cancer linked to asbestos exposure. Early diagnosis and surgical intervention were crucial for this aggressive asbestos-related malignancy.

Area of Science:

  • Oncology
  • Pathology
  • Epidemiology

Background:

  • Mesothelioma is a rare neoplasm arising from mesothelial cells, affecting serous cavities like the pleura and peritoneum.
  • Asbestos exposure is a known etiological factor for malignant mesothelioma, with risk correlating to cumulative exposure.
  • Malignant mesothelioma is an aggressive cancer with insidious symptoms, complicating diagnosis and treatment.

Observation:

  • A 59-year-old male electrician with a 40-year history of asbestos exposure presented with weight loss, abdominal pain, and fatigue.
  • Imaging revealed a large tumor in the upper abdomen, apparently originating from the spleen's superior pole.
  • Surgical exploration identified a vascularized, cystic tumor adherent to the diaphragm, spleen, and stomach.

Findings:

  • Surgical ablation of the tumor and splenectomy were performed.
  • The patient experienced a favorable postoperative recovery.
  • The patient is currently undergoing chemotherapy for malignant peritoneal mesothelioma.

Implications:

  • This case highlights the importance of considering asbestos exposure in patients with unexplained abdominal malignancies.
  • Aggressive surgical management combined with adjuvant chemotherapy can be effective for malignant peritoneal mesothelioma.
  • Further research into the long-term outcomes and optimal treatment strategies for peritoneal mesothelioma is warranted.